Page 20 - Read Online

Page 12 of 15 Miura et al. Vessel Plus 2019;3:1 I http://dx.doi.org/10.20517/2574-1209.2018.69

9. Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, et al. High-dose atorvastatin after stroke or transient
ischemic attack. N Engl J Med 2006;355:549-59.
10. Hosomi N, Kitagawa K, Nagai Y, Nakagawa Y, Aoki S, et al. Desirable low-density lipoprotein cholesterol levels for preventing stroke
recurrence: a post hoc analysis of the J-STARS study (Japan Statin Treatment Against Recurrent Stroke). Stroke 2018;49:865-71.
11. Prasad K. Do statins have a role in reduction/prevention of post- PCI restenosis? Cardiovasc Ther 2013;31:12-26.
12. Crouse JR, Byington RP, Bond MG, Espeland MA, Sprinkle JW, et al. Pravastatin, lipids, and atherosclerosis in the carotid arteries:
design features of a clinical trial with carotid atherosclerosis outcome. Control Clin Trials 1992;13:495-506.
13. Espeland MA, O’Leary DH, Terry JG, Morgan T, Evans G, et al. Carotid intimal-media thickness as a surrogate for cardiovascular
disease events in trials of HMG-CoA reductase inhibitors. Curr Control Trials Cardiovasc Med 2005;6:3.
14. Bedi US, Singh M, Singh PP, Bhuriya R, Bahekar A, et al. Effects of statins on progression of carotid atherosclerosis as measured by
carotid intimal--medial thickness: a meta-analysis of randomized controlled trials. J Cardiovasc Pharmacol Ther 2010;15:268-73.
15. Koga M, Toyoda K, Minematsu K, Yasaka M, Nagai Y, et al. Long-term effect of pravastatin on carotid intima-media complex
thickness: the J-STARS echo study (Japan Statin Treatment Against Recurrent Stroke). Stroke 2018;49:107-13.
16. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, et al. Lipid lowering by simvastatin induces regression of human atherosclerotic
lesions: two years’ follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 2002;106:2884-7.
17. Ainsworth CD, Blake CC, Tamayo A, Beletsky V, Fenster A, et al. 3D ultrasound measurement of change in carotid plaque volume: a
tool for rapid evaluation of new therapies. Stroke 2005;36:1904-9.
18. Tang TY, Howarth SP, Miller SR, Graves MJ, Patterson AJ, et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of
Macrophage Activity) study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid
disease. J Am Coll Cardiol 2009;53:2039-50.
19. Mujaj B, Bos D, Selwaness M, Leening MJG, Kavousi M, et al. Statin use is associated with carotid plaque composition: the Rotterdam
study. Int J Cardiol 2018;260:213-8.
20. Prasad K. Pathophysiology of atherosclerosis. In: Chang JB, Olsen ER, Prasad K, Sumpio BE, editors. Textbook of Angiology. New
Yor: Springer Verlag; 2000. pp. 85-105.
21. Prasad K. Pathophysiology and medical treatment of carotid artery stenosis. Int J Angiol 2015;24:158-72.
22. Orekhov AN, Ivanova EA. Introduction of the special issue “Atherosclerosis and Related Diseases”. Vessel Plus 2017;1:163-5.
23. Schaffner T, Taylor K, Bartucci EJ, Fischer-Dzoga K, Beeson JH, et al. Arterial foam cells with distinctive immunomorphologic and
histochemical features of macrophages. Am J Pathol 1980;100:57-80.
24. Hundal RS, Salh BS, Schrader JW, Gómez-Muñoz A, Duronio V, et al. Oxidized low density lipoprotein inhibits macrophage apoptosis
through activation of the PI 3-kinase/PKB pathway. J Lipid Res 2001;42;1483-91.
25. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in
vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-503.
26. Moreno PR, Purushothaman KR, Zias E, Sanz J, Fuster V. Neovascularization in human atherosclerosis. Curr Mol Med 2006;6:457-77.
27. Carr S, Farb A, Pearce WH, Virmani R, Yao JS. Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg
1996;23:755-65.
28. Morgan AR, Rerkasem K, Gallagher PJ, Zhang B, Morris GE, et al. Differences in matrix metalloproteinase-1 and matrix
metalloproteinase-12 transcript levels among carotid atherosclerotic plaques with different histopathological characteristics. Stroke
2004;35:1310-5.
29. Montecucco F, Di Marzo V, da Silva RF, Vuilleumier N, Capettini L, et al. The activation of the cannabinoid receptor type 2 reduces
neutrophilic protease-mediated vulnerability in atherosclerotic plaques. Eur Heart J 2012;33:846-56.
30. Rao VH, Rai V, Stoupa S, Subramanian S, Agrawal DK. Tumor necrosis factor-α regulates triggering receptor expressed on myeloid
cells-1-dependent matrix metalloproteinases in the carotid plaques of symptomatic patients with carotid stenosis. Atherosclerosis
2016;248:160-9.
31. Fang Y, Mohler ER 3rd, Hsieh E, Osman H, Hashemi SM, et al. Hypercholesterolemia suppresses inwardly rectifying K+ channels in
aortic endothelium in vitro and in vivo. Circ Res 2006;98:1064-71.
32. Morikage N, Kishi H, Sato M, Guo F, Shirao S, et al. Cholesterol primes vascular smooth muscle to induce Ca2 sensitization mediated
by a sphingosylphosphorylcholine-Rho-kinase pathway: possible role for membrane raft. Circ Res 2006;99:299-306.
33. Amiya E. Interaction of hyperlipidemia and reactive oxygen species: insights from the lipid-raft platform. World J Cardiol 2016;8:689-94.
34. Podrez EA, Poliakov E, Shen Z, Zhang R, Deng Y, et al. Identification of a novel family of oxidized phospholipids that serve as ligands
for the macrophage scavenger receptor CD36. J Biol Chem 2002;277:38503-16.
35. Zhang Q, Malik P, Pandey D, Gupta S, Jagnandan D, et al. Paradoxical activation of endothelial nitric oxide synthase by NADPH
oxidase. Arterioscler Thromb Vasc Biol 2008;28:1627-33.
36. Borén J, Taskinen MR, Olofsson SO, Levin M. Ectopic lipid storage and insulin resistance: a harmful relationship. J Intern Med
2013;274:25-40.
37. Wang L, Gill R, Pedersen TL, Higgins LJ, Newman JW, et al. Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs
that induce endothelial cell inflammation. J Lipid Res 2009;50:204-13.
38. Welty FK. How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis? Curr Cardiol Rep
2013;15:400.
39. Botham KM, Moore EH, De Pascale C, Bejta F. The induction of macrophage foam cell formation by chylomicron remnants. Biochem